Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03014804 |
|
Recruitment Status :
Withdrawn
(Final contract negotiations)
First Posted : January 9, 2017
Last Update Posted : July 24, 2020
|
Sponsor:
Jonsson Comprehensive Cancer Center
Collaborators:
Northwest Biotherapeutics
Bristol-Myers Squibb
Brain Tumor Funders Collaborative
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | December 1, 2020 |
| Estimated Study Completion Date : | December 1, 2022 |